Health
China favors first nasal spray COVID-19 antibody for preliminaries – Microbioz India
China has approved for trials its initial nasal spray vaccine to combat the novel coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally, official media here reported on September 10.
China’s only nasal spray vacc…
China has approved for trials its initial nasal spray vaccine to combat the novel coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally, official media here reported on September 10.
China’s only nasal spray vaccine against the coronavirus is anticipated to start phase I clinical trials in November, and it’s recruiting 100 volunteers. It is the only vaccine of its kind approved by China’s National Medical Products Administration, the state-run Global …
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
General23 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General23 hours agoWhy do states and territories have different school holidays?
-
Business24 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!